SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-20-016372
Filing Date
2020-06-30
Accepted
2020-06-30 18:11:22
Documents
2
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 3271
2 POWER OF ATTORNEY ea123397ex24-1_panacea.htm EX-24.1 5474
  Complete submission text file 0001213900-20-016372.txt   10074
Mailing Address C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO CA 94949
Business Address
Sharp Shalini (Reporting) CIK: 0001377202 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39351 | Film No.: 201003405

Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Panacea Acquisition Corp (Issuer) CIK: 0001811063 (see all company filings)

IRS No.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 6770 Blank Checks
Office of Real Estate & Construction